One mechanism connecting diabetes mellitus to higher mortality rates among COVID-19 patients is the presence of an underlying pro-inflammatory milieu, as suggested by the finding that circulating levels of some cytokines, such as interleukin-6 (IL-6), are higher in COVID-19 patients with diabetes mellitus. This evidence concerns the gene IL6 and COVID-19.